These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17828507)

  • 1. Expression and prognostic significance of survivin in the progression of bladder transitional cell cancer.
    Wang Y; Zhu Z; Zeng F; Wang L; Wu Y; Xia W; Xing S
    J Huazhong Univ Sci Technolog Med Sci; 2007 Aug; 27(4):444-7. PubMed ID: 17828507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer.
    Gazzaniga P; Gradilone A; Giuliani L; Gandini O; Silvestri I; Nofroni I; Saccani G; Frati L; Aglianò AM
    Ann Oncol; 2003 Jan; 14(1):85-90. PubMed ID: 12488298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expressions of survivin and the splice variants survivin-2B and survivin-DeltaEx3 in bladder cancer and their clinical significance].
    He XF; Wen DG; Hou JQ; He J; Cen JN
    Ai Zheng; 2009 Nov; 28(11):1209-13. PubMed ID: 19895744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of tumor relapse and elevated expression of survivin and vascular endothelial growth factor in superficial bladder transitional cell carcinoma.
    Sun YW; Xuan Q; Shu QA; Wu SS; Chen H; Xiao J; Xiang P; Zhu YP; Wang FL; Zhao ST
    Genet Mol Res; 2013 Apr; 12(2):1045-53. PubMed ID: 23613251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of Survivin in transitional cell carcinoma of urinary bladder and its clinical significance].
    Xiao ZJ; Zheng S; Chen W; Zhang HF; Li CL; Gao YN
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1977-9. PubMed ID: 15730809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
    Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N
    Urol J; 2009; 6(2):101-8. PubMed ID: 19472128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survivin protein expression positively correlated with proliferative activity of cancer cells in bladder cancer.
    Wu Y; Wang G; Wei J; Wen X
    Indian J Med Sci; 2005 Jun; 59(6):235-42. PubMed ID: 15988093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and prognostic significance of Livin in the progression of bladder cancer.
    Zhu Z; Wang Y; Ding X; Zeng F; Xu K
    J Huazhong Univ Sci Technolog Med Sci; 2008 Feb; 28(1):90-2. PubMed ID: 18278467
    [TBL] [Abstract][Full Text] [Related]  

    Kehinde EO; Al-Maghrebi M; Anim JT; Kapila K; George SS; Al-Juwaiser A; Memon A
    East Afr Med J; 2013 Jan; 90(1):19-27. PubMed ID: 26862626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silibinin down-regulates survivin protein and mRNA expression and causes caspases activation and apoptosis in human bladder transitional-cell papilloma RT4 cells.
    Tyagi AK; Agarwal C; Singh RP; Shroyer KR; Glode LM; Agarwal R
    Biochem Biophys Res Commun; 2003 Dec; 312(4):1178-84. PubMed ID: 14651997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.
    Weikert S; Christoph F; Schrader M; Krause H; Miller K; Müller M
    Int J Cancer; 2005 Aug; 116(1):100-4. PubMed ID: 15761870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer.
    Atlasi Y; Mowla SJ; Ziaee SA
    Cancer Detect Prev; 2009; 32(4):308-13. PubMed ID: 19186007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The apoptosis inhibitor survivin in transitional cell carcinoma of the urinary bladder].
    Vol'pina OM; Zavalishina LE; Volkova TD; Akhidova EV; Koroev DO; Andreeva IuIu; Petrov AN; Frank GA
    Arkh Patol; 2011; 73(2):8-10. PubMed ID: 21695980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin and MKI67 mRNA expression in bladder washings of patients with superficial urothelial cell carcinoma correlate with tumor stage and grade but do not predict tumor recurrence.
    Schultz IJ; Kiemeney LA; Willems JL; Swinkels DW; Witjes JA; de Kok JB
    Clin Chem; 2006 Jul; 52(7):1440-2. PubMed ID: 16798976
    [No Abstract]   [Full Text] [Related]  

  • 15. [Expression of survivin mRNA in urine exfoliated cells of patients with bladder transitional cell carcinoma detected by real-time PCR].
    Sun J; Hou JQ; He J; He XF; Wen DG
    Ai Zheng; 2009 Oct; 28(10):1100-2. PubMed ID: 19799821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of distributions of survivin among tissues from urinary bladders of dogs with cystitis, transitional cell carcinoma, or histologically normal urinary bladders.
    Rankin WV; Henry CJ; Turnquist SE; Turk JR; Beissenherz ME; Tyler JW; Green JA
    Am J Vet Res; 2008 Aug; 69(8):1073-8. PubMed ID: 18672973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression and significance of survivin mRNA in urinary bladder carcinomas.
    Wang H; Xi X; Kong X; Huang G; Ge G
    J Cancer Res Clin Oncol; 2004 Aug; 130(8):487-90. PubMed ID: 15138808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinico-pathological significance of protein expression of PAK1 in bladder transitional cell carcinoma].
    Zhang YH; Xie D; Luo JH; Chen W; Chen LW; Xu QC; Liu GY; Ma HB; Lin WQ
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2710-3. PubMed ID: 18167251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of survivin, a novel inhibitor of apoptosis, in superficial transitional cell carcinoma of the bladder.
    Ku JH; Kwak C; Lee HS; Park HK; Lee E; Lee SE
    J Urol; 2004 Feb; 171(2 Pt 1):631-5. PubMed ID: 14713775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical localization of the IAP protein survivin in bladder mucosa and transitional cell carcinoma.
    Lehner R; Lucia MS; Jarboe EA; Orlicky D; Shroyer AL; McGregor JA; Shroyer KR
    Appl Immunohistochem Mol Morphol; 2002 Jun; 10(2):134-8. PubMed ID: 12051631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.